NO20081220L - Nytt cercosporamidderivat - Google Patents
Nytt cercosporamidderivatInfo
- Publication number
- NO20081220L NO20081220L NO20081220A NO20081220A NO20081220L NO 20081220 L NO20081220 L NO 20081220L NO 20081220 A NO20081220 A NO 20081220A NO 20081220 A NO20081220 A NO 20081220A NO 20081220 L NO20081220 L NO 20081220L
- Authority
- NO
- Norway
- Prior art keywords
- group
- alkyl group
- halogenated
- hydrogen atom
- cercosporamide derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Oppfinnelsen vedrører et nytt cercosporamidderivat som har en god hypoglykemisk effekt og er anvendbart til et terapeutisk legemiddel og/eller profylaktisk legemiddel for sukkersyke, et farmakologisk akseptabelt salt derav eller en ester derav. Cercosporamid-derivatet har den generelle formel (I): hvor X er et oksygenatom eller lignende; R1 er et hydrogenatom eller en C1-C6-alkylgruppe; R2 er et hydrogenatom, en C1-C6-alkylgruppe eller en halogenert C1-C6-alkylgruppe; R3 er et hydrogenatom eller en C1-C6-alkylgruppe; R4 er en C6-C10-arylgruppe som kan være substituert med 1-5 grupper uavhengig valgt fra substituentgruppe (a) eller lignende; n er 1, 2 eller 3; og substituentgruppen (a) er et halogenatom, en C1-C6-alkylgruppe, en halogenert C1-C6-alkylgruppe, en C2-C6-alkenylgruppe, en C2-C6-alkynylgruppe, en C1-C6-alkoksy-gruppe, en halogenert C1-C6-alkoksy-gruppe, en C2_C6-alkenyloksygruppe, en C2-C6-alkynyloksygruppe og lignende.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005230558 | 2005-08-09 | ||
JP2005379060 | 2005-12-28 | ||
PCT/JP2006/315621 WO2007018193A1 (ja) | 2005-08-09 | 2006-08-08 | 新規セルコスポラミド誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081220L true NO20081220L (no) | 2008-05-08 |
Family
ID=37727376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081220A NO20081220L (no) | 2005-08-09 | 2008-03-07 | Nytt cercosporamidderivat |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090036492A1 (no) |
EP (1) | EP1914229B1 (no) |
JP (1) | JP4085129B2 (no) |
KR (1) | KR20080033367A (no) |
AU (1) | AU2006277289A1 (no) |
CA (1) | CA2618622A1 (no) |
DE (1) | DE602006014973D1 (no) |
IL (1) | IL189172A0 (no) |
NO (1) | NO20081220L (no) |
RU (1) | RU2008108997A (no) |
TW (1) | TW200740786A (no) |
WO (1) | WO2007018193A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2007018194A1 (ja) * | 2005-08-09 | 2009-02-19 | 第一三共株式会社 | セルコスポラミドの製造方法 |
WO2008096769A1 (ja) * | 2007-02-08 | 2008-08-14 | Daiichi Sankyo Company, Limited | 置換されたセルコスポラミド誘導体を含有する医薬 |
PL216649B1 (pl) | 2011-06-06 | 2014-04-30 | Univ Warszawski | Nowe kompleksy rutenu, sposób ich wytwarzania oraz zastosowanie w reakcji metatezy olefin |
CN103755827B (zh) * | 2014-01-16 | 2015-12-09 | 合肥工业大学 | 粒毛盘菌胞外多糖羧甲基化衍生物及其制抗肾衰药的用途 |
WO2016074696A1 (en) * | 2014-11-10 | 2016-05-19 | Givaudan Ag | Perfume ingredients and perfume preparations containing same |
JP2019510061A (ja) * | 2016-03-31 | 2019-04-11 | サウス オーストラリアン ヘルス アンド メディカル リサーチ インスティテュート リミテッドSouth Australian Health And Medical Research Institute Limited | 高脂肪食関連疾患を阻害する方法 |
JP7091958B2 (ja) * | 2018-09-11 | 2022-06-28 | 株式会社デンソー | 射出成形品の製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3825840A1 (de) * | 1988-07-29 | 1990-02-01 | Basf Ag | Dihydrodibenzofuranderivate und diese verbindungen enthaltende fungizide |
KR20040072697A (ko) * | 2001-12-31 | 2004-08-18 | 액테리온 파마슈티칼 리미티드 | 피롤리돈 카르복사미드 |
-
2006
- 2006-08-08 EP EP06796306A patent/EP1914229B1/en not_active Not-in-force
- 2006-08-08 AU AU2006277289A patent/AU2006277289A1/en not_active Abandoned
- 2006-08-08 TW TW095128965A patent/TW200740786A/zh unknown
- 2006-08-08 WO PCT/JP2006/315621 patent/WO2007018193A1/ja active Application Filing
- 2006-08-08 KR KR1020087003087A patent/KR20080033367A/ko not_active Application Discontinuation
- 2006-08-08 DE DE602006014973T patent/DE602006014973D1/de active Active
- 2006-08-08 US US11/990,289 patent/US20090036492A1/en not_active Abandoned
- 2006-08-08 JP JP2007529584A patent/JP4085129B2/ja not_active Expired - Fee Related
- 2006-08-08 RU RU2008108997/04A patent/RU2008108997A/ru unknown
- 2006-08-08 CA CA002618622A patent/CA2618622A1/en not_active Abandoned
-
2008
- 2008-02-03 IL IL189172A patent/IL189172A0/en unknown
- 2008-03-07 NO NO20081220A patent/NO20081220L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200740786A (en) | 2007-11-01 |
JP4085129B2 (ja) | 2008-05-14 |
WO2007018193A1 (ja) | 2007-02-15 |
AU2006277289A1 (en) | 2007-02-15 |
EP1914229A1 (en) | 2008-04-23 |
DE602006014973D1 (de) | 2010-07-29 |
RU2008108997A (ru) | 2009-09-20 |
JPWO2007018193A1 (ja) | 2009-02-19 |
IL189172A0 (en) | 2008-06-05 |
EP1914229B1 (en) | 2010-06-16 |
EP1914229A4 (en) | 2009-03-18 |
KR20080033367A (ko) | 2008-04-16 |
US20090036492A1 (en) | 2009-02-05 |
CA2618622A1 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081220L (no) | Nytt cercosporamidderivat | |
ATE388146T1 (de) | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor | |
TW200833675A (en) | Nicotinamide derivatives | |
NO20076498L (no) | Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren | |
MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
NO20084338L (no) | Neurogenesis fremkaller eller terapeutisk neuropatimiddel omfattende alkyl eter derivater eller salter derav | |
NO20084127L (no) | Benzylfenylglukopyranosidderivat | |
NO20076524L (no) | Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
NO20072409L (no) | Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser | |
NO20081315L (no) | Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser | |
NO20076196L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
NO20063446L (no) | Tiazolderivater | |
NO20091599L (no) | Kjemiske forbindelser | |
WO2008078196A3 (en) | Substituted heteroaryl pyridopyrimidone derivatives | |
NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
NO20054135L (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
NO20085269L (no) | 2-tioksantinderivater som fungerer som MPO-inhibitorer | |
NO20075409L (no) | Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater | |
NO20091301L (no) | Nye aminopyridinderivater med aurora A selektiv inhiberende aktivitet | |
NO20065327L (no) | Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid. | |
NO20075617L (no) | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |